Cargando…
Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis
AIMS: To compare the baseline cardiovascular characteristics of immunoglobulin light-chain (AL) and amyloid transthyretin (ATTR) cardiac amyloidosis (CA) and to investigate patients’ contemporary cardiac outcomes. METHODS: Single-center analysis of clinical, laboratory, echocardiographic and cardiac...
Autores principales: | Itzhaki Ben Zadok, Osnat, Vaturi, Mordehay, Vaxman, Iuliana, Iakobishvili, Zaza, Rhurman-Shahar, Noa, Kornowski, Ran, Hamdan, Ashraf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351987/ https://www.ncbi.nlm.nih.gov/pubmed/34370783 http://dx.doi.org/10.1371/journal.pone.0255487 |
Ejemplares similares
-
The short and long‐term characteristics and outcomes of patients with grade 1 myocardial uptake on cardiac scintigraphy
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2023) -
Transthyretin cardiac amyloidosis
por: Tomoaia, Raluca, et al.
Publicado: (2021) -
Transthyretin cardiac amyloidosis
por: Porcari, Aldostefano, et al.
Publicado: (2022) -
Cardiac Resynchronization Therapy for Transthyretin Cardiac Amyloidosis
por: Donnellan, Eoin, et al.
Publicado: (2020) -
Immune-Checkpoint Inhibitor-Induced Fulminant Myocarditis and Cardiogenic Shock
por: Itzhaki Ben Zadok, Osnat, et al.
Publicado: (2019)